CN111366735B - 新型冠状病毒更早期筛查方法 - Google Patents
新型冠状病毒更早期筛查方法 Download PDFInfo
- Publication number
- CN111366735B CN111366735B CN202010203742.XA CN202010203742A CN111366735B CN 111366735 B CN111366735 B CN 111366735B CN 202010203742 A CN202010203742 A CN 202010203742A CN 111366735 B CN111366735 B CN 111366735B
- Authority
- CN
- China
- Prior art keywords
- cov
- sars
- protein
- antibody
- 2iga
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/76—Chemiluminescence; Bioluminescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/587—Nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010203742.XA CN111366735B (zh) | 2020-03-20 | 2020-03-20 | 新型冠状病毒更早期筛查方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010203742.XA CN111366735B (zh) | 2020-03-20 | 2020-03-20 | 新型冠状病毒更早期筛查方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111366735A CN111366735A (zh) | 2020-07-03 |
CN111366735B true CN111366735B (zh) | 2021-07-13 |
Family
ID=71204552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010203742.XA Active CN111366735B (zh) | 2020-03-20 | 2020-03-20 | 新型冠状病毒更早期筛查方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111366735B (zh) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111690060A (zh) * | 2020-07-06 | 2020-09-22 | 深圳市亚辉龙生物科技股份有限公司 | 能够特异性识别RBD蛋白的IgA抗体以及试剂盒 |
CN111848754B (zh) * | 2020-08-10 | 2021-10-08 | 迈克生物股份有限公司 | 新型冠状病毒n蛋白重组抗原及其用途 |
CN116096736A (zh) * | 2020-08-14 | 2023-05-09 | 武汉友微生物技术有限公司 | 新型冠状病毒rbd融合蛋白 |
CN112028977A (zh) * | 2020-08-18 | 2020-12-04 | 上海纳米技术及应用国家工程研究中心有限公司 | 一种新型冠状病毒n蛋白抗原变体及其在新型冠状病毒抗体检测中的应用 |
CN112114140A (zh) * | 2020-09-11 | 2020-12-22 | 博奥赛斯(天津)生物科技有限公司 | 一种新型冠状病毒IgA抗体胶体金检测试剂盒 |
CN111926040B (zh) * | 2020-10-12 | 2021-01-26 | 天津中逸安健生物科技有限公司 | 一种新型冠状病毒rbd核苷酸序列、优化方法与应用 |
CN112239500B (zh) * | 2020-10-29 | 2022-01-07 | 东莞市朋志生物科技有限公司 | 抗新型冠状病毒的抗体和检测新型冠状病毒的试剂盒 |
CN112442120A (zh) * | 2020-11-25 | 2021-03-05 | 苏州大学 | 抗严重急性呼吸系统综合征ii型冠状病毒sars-cov-2的中和抗体 |
CN114858903A (zh) * | 2021-02-04 | 2022-08-05 | 北京毅新博创生物科技有限公司 | 用于诊断新冠肺炎的特征多肽组合物 |
CN112964874B (zh) * | 2021-02-22 | 2022-11-01 | 深圳市亚辉龙生物科技股份有限公司 | 基于间接法的SARS-CoV-2检测试剂盒 |
CN113185584B (zh) * | 2021-04-22 | 2023-04-11 | 龙湖现代免疫实验室 | 重组SARS-CoV-2 N蛋白及其制备方法、应用、及动物用新型冠状病毒ELISA抗体检测试剂盒 |
CN114295829B (zh) * | 2021-12-31 | 2022-11-04 | 中国医科大学附属第一医院 | 新型冠状病毒抗原和总抗体联合检测试剂盒及检测方法 |
CN114231497B (zh) * | 2022-02-24 | 2022-05-20 | 广州伯尼兹生物科技有限公司 | 一株表达SARS-CoV-2 S1蛋白单克隆抗体杂交瘤细胞系及中和活性抗体 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1177224C (zh) * | 2003-04-26 | 2004-11-24 | 杭州华大基因研发中心 | 检测sars冠状病毒抗体的方法及其试剂盒 |
AU2004245896A1 (en) * | 2003-06-10 | 2004-12-16 | Agency For Science, Technology And Research | Method of diagnosing SARS corona virus infection |
CN1826356B (zh) * | 2003-07-22 | 2012-05-09 | 克鲁塞尔荷兰公司 | 针对sars冠状病毒的结合分子及其应用 |
US20050112559A1 (en) * | 2003-09-29 | 2005-05-26 | The Chinese University Of Hong Kong | Compositions and methods for diagnosing and preventing severe acute respiratory syndrome (SARS) |
CN1902230A (zh) * | 2003-10-31 | 2007-01-24 | 富士瑞必欧株式会社 | 抗sars病毒抗体、产生该抗体的杂交瘤和使用该抗体的免疫测定试剂 |
US7750123B2 (en) * | 2003-11-25 | 2010-07-06 | Dana Farber Cancer Institute, Inc. | Antibodies against SARS-CoV and methods of use thereof |
CN111351927A (zh) * | 2020-03-17 | 2020-06-30 | 陈韬 | 针对病原体抗原的抗体矩阵检测法(mega法)及多联检测卡 |
-
2020
- 2020-03-20 CN CN202010203742.XA patent/CN111366735B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN111366735A (zh) | 2020-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111366735B (zh) | 新型冠状病毒更早期筛查方法 | |
CN111366734B (zh) | 双指标筛选新冠病毒及预判重型肺炎的方法 | |
KR102535195B1 (ko) | 항-코로나바이러스 항체 및 사용 방법 | |
Maillard et al. | Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients | |
CN109666070A (zh) | 单克隆抗体mers-4v2及其编码基因和应用 | |
CN108578692B (zh) | 白细胞介素-1α抗体及使用方法 | |
WO2008003236A1 (fr) | Procédé de détection conjointe de l'antigène pres1 et de l'antigène de noyau de vhb, coffret d'expérimentation, substrat solide et solution de lyse de virus | |
CN113388029B (zh) | 针对新型冠状病毒的中和性人源单克隆抗体及其应用 | |
CN110804099B (zh) | 人cd70抗原结合多肽 | |
KR20070012838A (ko) | B형간염 바이러스의 검출방법 | |
CN111434681B (zh) | 抗h7n9全人源单克隆抗体6j15及其制备方法与应用 | |
CN111434685B (zh) | 抗h7n9全人源单克隆抗体9i17及其制备方法与应用 | |
CN111320686B (zh) | 抗h7n9全人源单克隆抗体2g3及其制备方法与应用 | |
CN102050878B (zh) | 抗人cd20人源化抗体、其制备方法及用途 | |
CN111434684A (zh) | 抗h7n9全人源单克隆抗体5q2及其制法与应用 | |
WO2019210144A1 (en) | Broadly neutralizing antibodies against hepatitis c virus | |
CN110746503A (zh) | 抗H7N9全人源单克隆抗体hIg311及其制法与应用 | |
JPH09504377A (ja) | Hcvレセプター結合を検出するためのアッセイ | |
AU2013352260A1 (en) | Humanized monoclonal antibodies against activated protein C and uses thereof | |
JP3873576B2 (ja) | 抗原結合固相の製造方法 | |
TW202229330A (zh) | 特異性結合SARS-CoV-2的抗原結合蛋白 | |
CN112961239B (zh) | Tim抑制剂及其应用 | |
CN117368459A (zh) | 标记抗体与其相关生物材料及在新冠病毒检测中的应用 | |
CN101798348B (zh) | 一种抗uPAR人源化抗体及其应用 | |
CN111234013B (zh) | 乙肝病毒的中和抗体b430及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200727 Address after: No.505, 506, 507, 508, 601, 602, 603, 604, 7-4 102, 108, no.8-2, Dengyun Road, tangbudong village, Nancun Town, Panyu District, Guangzhou City, Guangdong Province Applicant after: GUANGZHOU KANGRUN BIOLOGICAL TECHNOLOGY Co.,Ltd. Applicant after: Guangdong Provincial Laboratory of regenerative medicine and health Address before: No.505, 506, 507, 508, 601, 602, 603, 604, 7-4 102, 108, no.8-2, Dengyun Road, tangbudong village, Nancun Town, Panyu District, Guangzhou City, Guangdong Province Applicant before: GUANGZHOU KANGRUN BIOLOGICAL TECHNOLOGY Co.,Ltd. |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: No.505, 506, 507, 508, 601, 602, 603, 604, 7-4 102, 108, no.8-2, Dengyun Road, tangbudong village, Nancun Town, Panyu District, Guangzhou City, Guangdong Province Applicant after: GUANGZHOU KANGRUN BIOLOGICAL TECHNOLOGY Co.,Ltd. Applicant after: Bioisland Laboratory Address before: No.505, 506, 507, 508, 601, 602, 603, 604, 7-4 102, 108, no.8-2, Dengyun Road, tangbudong village, Nancun Town, Panyu District, Guangzhou City, Guangdong Province Applicant before: GUANGZHOU KANGRUN BIOLOGICAL TECHNOLOGY Co.,Ltd. Applicant before: Guangdong Provincial Laboratory of regenerative medicine and health |
|
GR01 | Patent grant | ||
GR01 | Patent grant |